Vaccine maker Biological E. has been selected to receive mRNA technology from the World Health Organization technology transfer hub.
After examining a number of proposals from India, the WHO's Advisory Committee on Vaccine Product Development has selected Biological E. as a recipient, the Hyderabad–based firm said on Monday.
Primarily set up to address the Covid-19 emergency, WHO’s technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer. WHO and partners will be working with the Indian government and Biological E to develop a roadmap and put in place training and support for the company to start producing mRNA vaccines as soon as possible, it said.
